64 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Completed Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: therapeutic autologous lymphocytes;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
22 Completed Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Ovarian Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboxyamidotriazole;   Drug: paclitaxel
23 Completed Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Neuroblastoma;   Retinoblastoma;   Sarcoma
Intervention: Radiation: iodine I 131 monoclonal antibody 3F8
24 Completed Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Infection
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
25 Completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: imatinib mesylate;   Other: pharmacological study;   Procedure: conventional surgery
26 Completed Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
27 Recruiting Temozolomide in Treating Patients With Low-Grade Glioma
Condition: CNS Tumor, Adult
Intervention: Drug: temozolomide
28 Completed Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib + Sirolimus
29 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
30 Completed BCX-1777 in Treating Patients With Refractory Cancer
Condition: Cancer
Intervention: Drug: forodesine hydrochloride
31 Completed Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
32 Active, not recruiting Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: nucleic acid sequencing;   Other: diagnostic laboratory biomarker analysis;   Other: fluorine F 18 fluorothymidine;   Other: immunohistochemistry staining method;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: fludeoxyglucose F 18;   Radiation: intensity-modulated radiation therapy
33 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo
34 Completed Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer
Intervention: Radiation: iodine I 131 monoclonal antibody 81C6
35 Unknown  Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: chemotherapy;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
36 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
37 Completed Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Neuroblastoma
Interventions: Procedure: surgical procedure;   Radiation: astatine At 211 monoclonal antibody 81C6
38 Completed Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases
Conditions: Brain and Central Nervous System Tumors;   Radiation Toxicity
Interventions: Dietary Supplement: EGb761;   Drug: donepezil hydrochloride;   Procedure: cognitive assessment
39 Completed Imatinib Mesylate in Treating Patients With Gliomas
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
40 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years